SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Sales for the quarter ended September 2024 of Rs. 27.06 million declined by -99.00% from Rs. 2703.00 millions.A big loss of -98.94% reported for the quarter ended September 2024 to Rs. 3.20  millions from Rs. 300.95 millions.Operating Profit reported a sharp decline to 9.47 millions from 707.96 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 27.06 2703.00 -99.00 331.62 5693.06 -94.18 12273.18 11519.57 6.54
Other Income 129.46 73.97 75.02 240.85 129.50 85.98 453.14 332.82 36.15
PBIDT 9.47 707.96 -98.66 75.54 1361.63 -94.45 2952.81 2553.74 15.63
Interest 4.11 211.38 -98.06 5.80 415.22 -98.60 510.96 921.66 -44.56
PBDT 5.36 496.58 -98.92 69.74 946.41 -92.63 6307.75 1365.60 361.90
Depreciation 2.16 131.88 -98.36 4.66 270.73 -98.28 533.03 573.62 -7.08
PBT 3.20 364.70 -99.12 65.08 675.68 -90.37 5774.72 791.98 629.15
TAX 0.00 63.75 0.00 0.00 204.24 0.00 1590.81 367.25 333.17
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -108.43 233.61 -146.41
PAT 3.20 300.95 -98.94 65.08 471.44 -86.20 4183.91 424.73 885.08
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 35.00 26.19 33.62 22.78 23.92 -4.76 24.06 22.17 8.53

Ind-Swift Lab. Share Price

132.00 -13.30 (-9.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×